Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
AstraZeneca, Immunai
AstraZeneca in AI Collaboration With Immunai to Inform Cancer Drug Trials
(Reuters) - AstraZeneca will pay $18 million to biotechnology firm Immunai Inc to use the New York-based firm's AI model of the immune system to make certain cancer drug trials more efficient, the latter said on Thursday.
AstraZeneca's experimental drug disappoints in breast cancer survival trial
AstraZeneca said on Monday its experimental precision drug developed with Japan's Daiichi Sankyo did not significantly improve overall survival for patients with a type of breast cancer in a late-stage trial.
Immunai, AstraZeneca collaborate to optimize cancer clinical trials
Under the terms of the agreement, AstraZeneca will leverage Immunai’s platform and machine learning capabilities to inform certain oncology clinical trials.
Israeli AI startup forges $18m partnership with AstraZeneca for cancer drug trials
As part of the collaboration, the drugmaker will use Immunai's AI model of the immune system and machine learning for clinical decision-making in drug discovery and development The post Israeli AI startup forges $18m partnership with AstraZeneca for cancer drug trials appeared first on The Times of Israel.
MM&M
1d
AstraZeneca’s ‘What science can do’ campaign highlights company’s scientific achievements
In several short films directed by Reed Morano, the “What science can do” campaign features stories from a cancer patient and an asthma patient.
2d
AstraZeneca rises Thursday, outperforms market
AstraZeneca PLC AZN shares rallied 1.33% to £117.20 Thursday, on what proved to be an all-around great trading session for ...
FierceBiotech
2d
AstraZeneca extends AI immuno-oncology R&D pact with Immunai
AstraZeneca is extending its work with Immunai through a multiyear collaboration that aims to implement its ...
2d
AstraZeneca's Top-Selling Cancer Drug Tagrisso Receives FDA Green Light For Another Lung Cancer Indication
The FDA has approved AstraZeneca's Tagrisso for treating unresectable, Stage III EGFR-mutated non-small cell lung cancer, ...
4d
AstraZeneca: Buy This Big Pharma Stock At A Discount Now
AstraZeneca topped the analyst consensus for net revenue and matched the analyst consensus for core EPS in Q2. See why I ...
FierceBiotech
5d
AstraZeneca, Daiichi's Trodelvy rival fails to improve overall survival in breast cancer trial
AstraZeneca and Daiichi Sankyo’s TROP2-directed antibody-drug conjugate (ADC) has again failed to improve overall survival ...
MarketWatch on MSN
4d
AstraZeneca falls Tuesday, underperforms market
Shares of AstraZeneca PLC AZN inched down 0.54% to £115.22 Tuesday, on what proved to be an all-around positive trading ...
2d
AstraZeneca: FDA Approves Tagrisso To Treat Unresectable Stage III Lung Cancer
British drug major AstraZeneca PLC (AZN, AZN.L) announced Thursday that its Tagrisso (osimertinib) has been approved in the US for ...
2d
As AstraZeneca’s share price drops 13% should I buy on the dip?
AstraZeneca’s share price has fallen following unfavourable results for one of its new drugs, but others look good, and ...
globes.co.il
1d
Israel's Immunai expands strategic tie with AstraZeneca
Immunai already has strategic agreements with 30 pharmaceuticals companies, most of them involving much smaller financial ...
Zacks.com on MSN
1d
AstraZeneca Stock Up Almost 14% in 6 Months: Time to Buy?
AstraZeneca AZN stock has risen 13.6% in the past six months, outperforming an increase of 7.1% for the industry. AstraZeneca ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Immunai
United States
Tagrisso
Artificial intelligence
Trade
Feedback